You are currently viewing a new version of our website. To view the old version click .
Journal: CancersVolume: 14Number: 682
Article: Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial
  • Authors:
  • Julia Katharina Schwarze1,*,
  • Soizic Garaud2 and
  • Yanina J. L. Jansen3
  • et al.
Link: https://www.mdpi.com/2072-6694/14/3/682

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.